| [1] |
Navarro VJ, Khan I, Bjrnsson E, et al. Liver injury from herbal and dietary supplements. Hepatology, 2017, 65:363-373.
|
| [2] |
Clarke TC, Black LI, Stussman BJ, et al. Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl Health Stat Report, 2015, 10:1-16.
|
| [3] |
Navarro VJ, Barnhart H, Bonkovsky HL, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology, 2014, 60:1399-1408.
|
| [4] |
Navarro VJ, Lucena MI. Hepatotoxicity induced by herbal and dietary supplements. Semin Liver Dis, 2014, 34:172-193.
|
| [5] |
Zhou Y, Yang L, Liao Z, et al. Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients. Eur J Gastroenterol Hepatol, 2013, 25:825-829.
|
| [6] |
Hillman L, Gottfried M, Whitsett M, et al. Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury. Am J Gastroenterol, 2016, 111: 958-965.
|
| [7] |
Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology, 2008, 135: 1924-1934.
|
| [8] |
Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology, 2010, 52:2065-2076.
|
| [9] |
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 中华肝脏病杂志, 2015, 23: 810-827.
|
| [10] |
Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guide: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol, 2014, 109: 950-966.
|
| [11] |
Bjrnsson E, Bergman OM, Bj rnsson HK, et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology, 2013, 144: 1419-1425.
|
| [12] |
Robles-Diaz M, Gonzalez-Jimenez A, Medina-Caliz I, et al. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Aliment Pharmacol Ther, 2015, 41: 116-135.
|
| [13] |
El Sherrif Y, Potts JR, Howard MR, et al. Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations Liver Int, 2013, 33:1266-1270.
|
| [14] |
Mazzanti G, Di Sotto A, Vitalone A. Hepatotoxicity of green tea: an update. Arch Toxicol, 2015, 89: 1175-1191.
|
| [15] |
Roytman MM, Przgen P, Lee CL, et al. Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am J Gastroenterol, 2014, 109: 1296-1298.
|
| [16] |
Betz JM, Brown PN, Roman MC. Accuracy, precision, and reliability of chemical measurements in natural products research. Fitoterapia, 2011, 82:44-52.
|
| [17] |
US Environmental Protection Agency. Toxicology testing in the 21st century (Tox21). www.epa.gov/chemical-research/toxicology-testing-21st-century-tox21. Published December 2015. Accessed February 21, 2016.
|
| [18] |
Alissa EM. Medicinal herbs and therapeutic drugs interactions. Ther Drug Monit, 2014, 36: 413-422.
|
